OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$20.88 USD
-0.80 (-3.69%)
Updated Oct 27, 2025 04:00 PM ET
After-Market: $20.26 -0.62 (-2.97%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPRX 20.88 -0.80(-3.69%)
Will OPRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for OPRX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for OPRX
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
OPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Growth Stocks to Buy for September 5th
Best Growth Stocks to Buy for September 3rd
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?
Other News for OPRX
Is OPRX likely to continue higher? New 52 Week Closing High shows up after soaring 10.67%
Crossed Above 20 Day Moving Average appears for OPRX after 4.09% move
OPRX Fell Below 20 Day Moving Average on October 22
Technical picture remains unchanged for OPRX after it falls 2.27% on October 21
OPRX forms NR7 on October 20